Circulating Mucosal Associated Invariant T Cells Are Activated in Vibrio cholerae O1 Infection and Associated with Lipopolysaccharide Antibody Responses

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Leung, Daniel T ^a,b,c,e   Bhuiyan, Taufiqur R ^a   Nishat, Naoshin S ^a   Hoq, Mohammad Rubel ^a   Aktar, Amena ^a   Rahman, M Arifur ^a   Uddin, Taher ^a   Khan, Ashraful I ^a   Chowdhury, Fahima ^a   Charles, Richelle C ^b,c   Harris, Jason B ^b,c   Calderwood, Stephen B ^b,c   Qadri, Firdausi ^a   Ryan, Edward T ^b,c,d  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD3 ANTIBODY; CD38 ANTIGEN; CD4 ANTIBODY; CD8 ANTIGEN; CHOLERA TOXIN B SUBUNIT; LIPOPOLYSACCHARIDE; BACTERIUM ANTIBODY; CHOLERA TOXIN; KLRB1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B;

ACUTE DIARRHEA; ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CD3+ T LYMPHOCYTE; CHILD; CHOLERA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES CULTURE; FEMALE; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; HUMAN; INTESTINE MUCOSA; MALE; MUCOSAL ASSOCIATED INVARIANT T CELL; PERIPHERAL CIRCULATION; PHENOTYPE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIBRIO CHOLERAE O1; BLOOD; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PRESCHOOL CHILD;

ADULT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CHOLERA; CHOLERA TOXIN; FEMALE; HUMANS; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; T-LYMPHOCYTES; VIBRIO CHOLERAE O1;

EID: 84935127824     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003076     Document Type: Article

References (43)

1. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB, (2012) Cholera. Lancet 379: 2466–2476.
2. Ali M, Lopez AL, You YA, Kim YE, Sah B, et al. (2012) The global burden of cholera. Bulletin of the World Health Organization 90: 209–218A.
3. Qadri F, Mohi G, Hossain J, Azim T, Khan AM, et al. (1995) Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clinical and diagnostic laboratory immunology 2: 685–688.
4. Harris JB, LaRocque RC, Chowdhury F, Khan AI, Logvinenko T, et al. (2008) Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS neglected tropical diseases 2: e221.
5. Patel SM, Rahman MA, Mohasin M, Riyadh MA, Leung DT, et al. (2012) Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clinical and vaccine immunology : CVI 19: 842–848.
6. Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, et al. (2012) Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clinical and vaccine immunology : CVI 19: 1304–1311.
7. Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, et al. (2009) Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infection and immunity 77: 3850–3856.
8. Kuchta A, Rahman T, Sennott EL, Bhuyian TR, Uddin T, et al. (2011) Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clinical and vaccine immunology : CVI 18: 1371–1377.
9. Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, et al. (2009) Memory T-cell responses to Vibrio cholerae O1 infection. Infection and immunity 77: 5090–5096.
10. Leung DT, Rahman MA, Mohasin M, Riyadh MA, Patel SM, et al. (2011) Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clinical and vaccine immunology : CVI 18: 1317–1325.
11. Qadri F, Raqib R, Ahmed F, Rahman T, Wenneras C, et al. (2002) Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clinical and diagnostic laboratory immunology 9: 221–229.
12. Qadri F, Bhuiyan TR, Dutta KK, Raqib R, Alam MS, et al. (2004) Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut 53: 62–69.
13. Shirin T, Rahman A, Danielsson A, Uddin T, Bhuyian TR, et al. (2011) Antimicrobial peptides in the duodenum at the acute and convalescent stages in patients with diarrhea due to Vibrio cholerae O1 or enterotoxigenic Escherichia coli infection. Microbes and infection/Institut Pasteur 13: 1111–1120.
14. Shin OS, Uddin T, Citorik R, Wang JP, Della Pelle P, et al. (2011) LPLUNC1 modulates innate immune responses to Vibrio cholerae. The Journal of infectious diseases 204: 1349–1357.
15. Le Bourhis L, Mburu YK, Lantz O, (2013) MAIT cells, surveyors of a new class of antigen: development and functions. Current opinion in immunology 25: 174–180.
16. Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, et al. (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117: 1250–1259.
17. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, et al. (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717–723.
18. Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, et al. (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nature immunology 11: 701–708.
19. Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, et al. (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS biology 8: e1000407.
20. Leeansyah E, Ganesh A, Quigley MF, Sonnerborg A, Andersson J, et al. (2013) Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. Blood 121: 1124–1135.
21. Cosgrove C, Ussher JE, Rauch A, Gartner K, Kurioka A, et al. (2013) Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121: 951–961.
22. Chua WJ, Truscott SM, Eickhoff CS, Blazevic A, Hoft DF, et al. (2012) Polyclonal mucosa-associated invariant T cells have unique innate functions in bacterial infection. Infection and immunity 80: 3256–3267.
23. Georgel P, Radosavljevic M, Macquin C, Bahram S, (2011) The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. Molecular immunology 48: 769–775.
24. Meierovics A, Yankelevich WJ, Cowley SC, (2013) MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proceedings of the National Academy of Sciences of the United States of America 110: E3119–3128.
25. Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, et al. (2013) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive care medicine 10.1007/s00134-013-3163-x.
26. Le Bourhis L, Dusseaux M, Bohineust A, Bessoles S, Martin E, et al. (2013) MAIT Cells Detect and Efficiently Lyse Bacterially-Infected Epithelial Cells. PLoS pathogens 9: e1003681.
27. Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, et al. (2013) CD161 CD8 T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. European journal of immunology 10.1002/eji.201343509.
28. Johnson RA, Uddin T, Aktar A, Mohasin M, Alam MM, et al. (2012) Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clinical and vaccine immunology : CVI 19: 1712–1721.
29. Qadri F, Ahmed F, Karim MM, Wenneras C, Begum YA, et al. (1999) Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera. Clinical and diagnostic laboratory immunology 6: 812–818.
30. Karlsson EK, Harris JB, Tabrizi S, Rahman A, Shlyakhter I, et al. (2013) Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Science translational medicine 5: 192ra186.
31. Berkey CD, Blow N, Watnick PI, (2009) Genetic analysis of Drosophila melanogaster susceptibility to intestinal Vibrio cholerae infection. Cellular microbiology 11: 461–474.
32. Wang Z, Berkey CD, Watnick PI, (2012) The Drosophila protein mustard tailors the innate immune response activated by the immune deficiency pathway. Journal of immunology 188: 3993–4000.
33. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, et al. (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479: 117–121.
34. Larocque RC, Sabeti P, Duggal P, Chowdhury F, Khan AI, et al. (2009) A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes and immunity 10: 267–272.
35. Lee OJ, Cho YN, Kee SJ, Kim MJ, Jin HM, et al. (2014) Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults. Experimental gerontology 49: 47–54.
36. Martin E, Treiner E, Duban L, Guerri L, Laude H, et al. (2009) Stepwise development of MAIT cells in mouse and human. PLoS biology 7: e54.
37. Reantragoon R, Corbett AJ, Sakala IG, Gherardin NA, Furness JB, et al. (2013) Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. The Journal of experimental medicine 210: 2305–2320.
38. Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, et al. (2013) Recognition of vitamin B metabolites by mucosal-associated invariant T cells. Nature communications 4: 2142.
39. Genomes KEoGa KEGG PATHWAY: Riboflavin metabolism - Vibrio cholerae O1 biovar El Tor N16961.
40. Keusch GT, Rosenberg IH, Denno DM, Duggan C, Guerrant RL, et al. (2013) Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in low- and middle-income countries. Food and nutrition bulletin 34: 357–364.
41. Taniuchi M, Sobuz SU, Begum S, Platts-Mills JA, Liu J, et al. (2013) Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. The Journal of infectious diseases 208: 1794–1802.
42. Germain C, Meier A, Jensen T, Knapnougel P, Poupon G, et al. (2011) Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-gamma contributes to modulate immune responses. The Journal of biological chemistry 286: 37964–37975.
43. Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A, (2013) Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? Clinical and experimental immunology 171: 8–19.